FLAP: a novel drug target for inhibiting the synthesis of leukotrienes
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 12 (2) , 68-70
- https://doi.org/10.1016/0165-6147(91)90500-r
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesisNature, 1990
- Identification and isolation of a membrane protein necessary for leukotriene productionNature, 1990
- The Long-term Effects of Nedocromil Sodium and Beclomethasone Dipropionate on Bronchial Responsiveness to Methacholine in Nonatopic Asthmatic SubjectsAmerican Review of Respiratory Disease, 1989
- The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonistCanadian Journal of Physiology and Pharmacology, 1989
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Formation and actions of leukotrienesPhysiological Reviews, 1984